IRIS International (IRIS) Offers 2012 Outlook Below Expectations
Tweet
Share
E-mailGet Alerts IRIS Hot Sheet
Price: $19.49 --0%
Financial Fact:
Sample processing instruments and supplies: 1.72M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Sample processing instruments and supplies: 1.72M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
IRIS International, Inc. (Nasdaq: IRIS) is announcing preliminary 2012 guidance at a meeting for investors and analysts on Friday, December 2, 2011 from 8:00am to 10:30am Eastern time, at the New York Athletic Club located at 180 Central Park South in New York, New York.
The Company is providing 2012 revenue guidance in a range of to $127 million - $131 million and GAAP EPS of $0.30 - $0.35, which includes the sales and marketing expense of a focused direct sales effort for ProsVue. The Company expects research and development expense to represent 15% to 16% of revenue in 2012. The Street is forecasting earnings of $0.39 per share on $128.9 million in sales for the year.
The Company is providing 2012 revenue guidance in a range of to $127 million - $131 million and GAAP EPS of $0.30 - $0.35, which includes the sales and marketing expense of a focused direct sales effort for ProsVue. The Company expects research and development expense to represent 15% to 16% of revenue in 2012. The Street is forecasting earnings of $0.39 per share on $128.9 million in sales for the year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
